Back to Journals » Patient Related Outcome Measures » Volume 9

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date

Total article views   HTML views PDF downloads Totals
19,219 Dovepress* 11,846+ 1,833 13,679
PubMed Central* 7,373 1,278 8,651
Totals 19,219 3,111 22,330
*Since 2 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar